1. Historical Origins and Spiritual Inheritance
Wuwei Cancer Hospital, also known as Wuwei Medical Science Research Institute (Wuwei Academy of Medical Sciences), was founded in 1978. After nearly fifty years of development, it became the first hospital in Jinchang and Wuwei to pass the national Grade III Class A hospital evaluation ten years ago. Adhering to the principle of "everything for the health of the people," the hospital has developed into a modern specialized cancer hospital with expertise in cancer diagnosis and treatment and heavy ion precision radiotherapy, and is one of the top 100 national model hospitals trusted by the people (one of the first four selected in Gansu Province).
2. Overall Scale and Hardware Capabilities
The hospital has a building area of approximately 60,000 square meters, 1,000 beds, and sees about 330,000 outpatients and 39,000 inpatients annually, performing over 8,000 surgical procedures. The hospital is equipped with advanced equipment including China's first heavy ion therapy system with completely independent intellectual property rights, the first domestically produced Tomahawk four-arm surgical robot, the fourth PET-CT scanner in Gansu Province and the first in a prefecture-level hospital in the province, a Siemens 3.0T high-end radiotherapy positioning MRI, an Elekta 4D image-guided medical linear accelerator, and a dynamic 500-slice gemstone spectral CT scanner. The hospital has established four provincial-level key disciplines (Gastroenterology, Radiation Oncology, Gastrointestinal Surgery, and Respiratory and Critical Care Medicine) and ten municipal-level key disciplines, serving as an innovative platform for the clinical application of high-end medical equipment and precision oncology treatment.
3. National Ranking and Authoritative Certification
The hospital is a Grade III Class A oncology hospital designated by the National Health Commission. It is the first hospital in China to clinically apply a heavy ion therapy system and the only hospital in the world operating two heavy ion cancer treatment systems. It ranks 7th nationwide among tumor particle (proton/heavy ion) therapy centers. The hospital manages and operates two heavy ion therapy systems with independent intellectual property rights in China: the Wuwei Heavy Ion Center and the Lanzhou Heavy Ion Center. It is a world-first hospital in several pioneering technologies, including completing treatment within one day with a single fractionation, precision heavy ion therapy under ventilator control, and bladder cancer treatment with precise bladder capacity control.
4. Core Business Data
Since its official clinical operation began in March 2020, the Wuwei Heavy Ion Center has provided precision heavy ion therapy to over 3,000 patients from China and abroad, relying on 30 interdisciplinary research platforms. Its services cover the entire country and extend to several countries. The Lanzhou Heavy Ion Center, which began operation in November 2024, has already treated hundreds of patients. The center treats a variety of solid tumors, including lung cancer, pancreatic cancer, liver cancer, glioma, and prostate cancer. It ranks among the top in China and is internationally advanced in terms of clinical application of heavy ion radiotherapy, technology development, annual patient treatment volume, and efficacy in key diseases.
5. MDT Multidisciplinary Collaboration System
The hospital has established a multidisciplinary heavy ion therapy team comprised of specialists in radiotherapy, oncology, surgery, imaging, pathology, anesthesiology, nursing, and physicists, focusing on precise heavy ion radiotherapy. This team conducts precise tumor target delineation, protects normal tissue, and develops personalized treatment plans. The Heavy Ion Center, relying on 30 interdisciplinary research platforms, has built a complete innovation ecosystem covering basic research, clinical translation, and成果转化 (technology dissemination), forming a collaborative medical-research partnership with the Institute of Modern Physics, Chinese Academy of Sciences.
6. International and Foreign-Related Medical Treatment System
The Wuwei Heavy Ion Center, as the first clinical application unit of China's independently developed heavy ion therapy system, makes China the fourth country in the world to master heavy ion therapy technology. The center has treated patients from multiple countries, and overseas Chinese media have repeatedly sent delegations to visit and report on it. Leveraging this national asset of heavy ion therapy, the hospital provides internationally standardized heavy ion precision radiotherapy services to cancer patients from Central Asia, West Asia, and around the world, serving as an important window for China's precision cancer treatment technology to reach the world.
